RETRACTED ARTICLE: LncRNA XIST inhibits ovarian cancer cell growth and metastasis via regulating miR-150-5p/PDCD4 signaling pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00210-020-01808-2.pdf
Reference47 articles.
1. Brungs D, Lochhead A, Iyer A et al (2019) Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma. Pathology
2. Chen Z, Hu X, Wu Y, Cong L, He X, Lu J, Feng J, Liu D (2019) Long non-coding RNA XIST promotes the development of esophageal cancer by sponging miR-494 to regulate CDK6 expression. Biomed Pharmacother 109:2228–2236
3. Clarke MF (2019) Clinical and therapeutic implications of cancer stem cells. N Engl J Med 380(23):2237–2245
4. Coburn SB, Bray F, Sherman ME et al (2017) International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer 140(11):2451–2460
5. Du Y, Weng XD, Wang L et al (2017) LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression. Oncotarget 8(55):94358–94370
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long noncoding RNA‐LINC00478 promotes the progression of clear cell renal cell carcinoma through PBX3;Journal of Biochemical and Molecular Toxicology;2022-09-09
2. Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy;Current Cancer Drug Targets;2021-09
3. The expression of NLK is functionally associated with colorectal cancers (CRC);Journal of Cancer;2021
4. Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review;Frontiers in Pharmacology;2020-12-14
5. Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer;Free Radical Biology and Medicine;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3